Effects of Abatacept in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis

Abstract

Abatacept statistically significantly reduced disease activity in patients with rheumatoid arthritis and an inadequate response to methotrexate. Longer treatment in different patient populations is needed to establish its appropriate role in rheumatoid arthritis.